Medical Digest & Congress Report

Giulia Magnani explains a nurse-coordinated intensive intervention program emphasizing lifestyle and behavioral changes after ACS was associated with a 30% reduction in major adverse CV events for patients, primarily driven by a reduction in nonfatal MI, according to a study presented at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/scientific-con...

Luke Laffin on the phase 2b Advance-HTN study of lorundrostat, whose results were reported in a late-breaking clinical trials presentation at the American College of Cardiology’s 2025 Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:lorundrostat-shows-continued-promise-against-uncontrolled-hypertension

Alan Brown shares his insights on lipoprotein(a) and atherosclerotic cardiovascular disease at the American College of Cardiology’s Annual Scientific Session. Why lipoprotein(a) matters for clinical decisions and patient risk? Video: https://medicaldigest.org/scientific-contents/interview:shifting-paradigm-lipoprotein-cardiovascular-disease

Raj Makkar explains data from 500 patients treated for aortic regurgitation with the Trilogy transcatheter aortic valve implantation system, point towards positive safety and efficacy outcomes with the device, alongside favourable valve performance at up to two years, according to a study presented at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/...

Ankeet S. Bhatt shares his insights how real-world evidence and implementation science can improve ASCVD care at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:evidence-generation-implementation-tackling-unmet-need-ascvd

Heather L. Gornik shares her insights on future of care for patients with peripheral artery disease with the 2024 guidelines'. Video: https://medicaldigest.org/scientific-contents/interview:stepping-future-care-patients-peripheral-artery-disease-2024-guidelines-report-acc25 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery...

Stefan D. Anker explains among iron-deficient patients with heart failure with reduced ejection fraction, receiving intravenous iron supplementation was found to be safe but resulted in mixed findings, according to a study presented at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:intravenous-iron-offers-some-benefits...

Marc P. Bonaca explains semaglutide significantly improved maximal walking distance in people with symptomatic peripheral arterial disease and type 2 diabetes in a trial designed to evaluate the use of a GLP-1 agonist to manage PAD, according to a study presented at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:semagl...

Michael J. Reardon explains the new five-year data suggest transcatheter aortic valve replacement with a supra-annular, self-expanding valve is a safe and effective alternative to surgical aortic valve replacement when treating low-risk patients. In fact, hemodynamic data after five years consistently favors a transcatheter approach, according to a study presented at the American College of Cardio...

Darren K. McGuire explains people taking an oral formulation of semaglutide were 14% less likely than those taking a placebo to experience cardiovascular death, heart attack or stroke after an average follow-up of four years, according to a study presented at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:oral-semaglut...

Joo-Yong Hahn shares his insights on the research presented at the American College of Cardiology's Annual Scientific Session. People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open blocked arteries, experienced significantly better outcomes with clopidogrel rather than aspirin as their long-term antiplatelet therapy, according...

Isabelle Mahé shares her insights API-CAT trial were presented at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:low-dose-apixiban-comparable-full-dose-preventing-vte-recurrence-patients-cancer

Eileen M. Handberg, PhD, ARNP, FACC and C. Noel Bairey Merz, MD, FACC, FAHA shares their insights on the WARRIOR study, presented at the American College of Cardiology Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:warrior-study-intensive-medical-therapy-does-not-help-or-harm-women-chest-pain

Michael Gnant have been the Co-Chair of the highly successful, annual St Gallen Breast Cancer Conference in Vienna, and chaired a session about the latest advances of CDK4/6 inhibitor treatment in HR+/HER2− early breast cancer, focusing on risk of recurrence. Video: https://medicaldigest.org/scientific-contents/interview:redefining-risk-recurrence-latest-advances-cdk46-inhibitors-hrher2-early-brea...

Sami Timimi indicated in his presentation at the RCPsych in Scotland Winter Conference that formal psychiatric diagnostic systems should be abolished. In our interview he explains why psychiatric labels do more harm than good. Video: https://medicaldigest.org/scientific-contents/interview:why-there-no-such-thing-psychiatric-diagnosis

Edoardo Ostinelli, Senior Researcher & Deputy Lead of Oxford Precision Psychiatry Lab at the Department of Psychiatry, University of Oxford, UK. He is the first author of a recently published article in Lancet Psychiatry about ADHD in adults. How important is this question? How many patients suffer from the disease? We asked him about the study. Video: https://medicaldigest.org/scientific-cont...

Sven Bölte, professor of child and adolescent psychiatric science at Karolinska Institute, Stockholm, Sweden, renowned expert of neurodevelopmental disorders. He is the first author of a recently published article in Neuroscience & Biobehavioral Reviews about social cognition in autism and ADHD. We asked him about the study. Article: Social cognition in autism and ADHD Video: https://medicaldi...

Mark Jankelow, MSN, PMHNP-BC summarizes his presentation at Real Psychiatry 2025 on bipolar disorder and ADHD and shares his 20 years of experience with treatments. Video: https://medicaldigest.org/scientific-contents/interview:addressing-comorbid-bipolar-disorder-and-adhd

Professor Paul G. Richardson summarizes the most important highlights in the field of Multiple Myeloma treatment after the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:management-multiple-myeloma-ash-2024

Kate Lathrop, MD discuss some of the high impact, clinically relevant, clinical trials that were presented at the San Antonio Breast Cancer Symposium 2024. The studies discussed: - (01:28) Circulating tumor DNA surveillance in ZEST, a randomized, phase 3, double-blind study of niraparib or placebo in patients w/ triple-negative breast cancer or HER2+ BRCA-mutated breast cancer with molecular resid...

Janice Tsang, MD discusses early breast cancer updates at San Antonio Breast Cancer Symposium 2024. Videó: https://medicaldigest.org/scientific-contents/interview:early-breast-cancer-updates

William G. Wierda, MD, PhD discusses current questions and state of the art treatement of chronic lymphocytic leukemia at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:cll-highlights-ash-2024

Josef T. Prchal, MD investigated the genetic basis underlying elevated hemoglobin in Andean natives, Aymara, by using granulocyte transcriptome data from both Aymara and Europeans from La Paz, Bolivia. They found their differentially expressed and spliced genes are associated with inflammatory and HIFs pathways. Video: https://medicaldigest.org/scientific-contents/interview:aymara-gene-tale-high-a...

Aaron Gerds, MD, MS discusses the state of the art treatment in polycythemia vera at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:state-art-treatment-polycythemia-vera

Aaron Gerds, MD, MS discusses the state of the art treatment in myelofibrosis at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:state-art-treatment-myelofibrosis